X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (152) 152
rna-positive cells (100) 100
female (98) 98
peripheral-blood (87) 87
index medicus (76) 76
oncology (72) 72
middle aged (60) 60
adult (59) 59
breast cancer (59) 59
breast neoplasms - pathology (51) 51
rna, messenger - genetics (51) 51
bone-marrow (50) 50
prognosis (49) 49
leukemia, myelogenous, chronic, bcr-abl positive - genetics (43) 43
aged (40) 40
male (39) 39
neoplastic cells, circulating - pathology (38) 38
adjuvant chemotherapy (37) 37
circulating tumor cells (36) 36
prognostic value (35) 35
metastasis (31) 31
neoplastic cells, circulating - metabolism (31) 31
polymerase-chain-reaction (30) 30
breast neoplasms - blood (29) 29
cancer (28) 28
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (28) 28
fusion proteins, bcr-abl - genetics (27) 27
molecular-detection (27) 27
messenger-rna (25) 25
reverse transcriptase polymerase chain reaction (25) 25
rna, messenger - metabolism (25) 25
neoplasm metastasis (23) 23
leukemia, myelogenous, chronic, bcr-abl positive - pathology (22) 22
research (22) 22
rt-pcr (22) 22
cell line, tumor (21) 21
chemotherapy (21) 21
adolescent (20) 20
k562 cells (20) 20
neoplasm staging (20) 20
breast neoplasms - diagnosis (19) 19
care and treatment (19) 19
expression (19) 19
breast neoplasms - drug therapy (18) 18
tumors (17) 17
antineoplastic agents - therapeutic use (16) 16
metastatic breast-cancer (16) 16
prognostic-significance (16) 16
cytokeratin-19 (15) 15
gene expression (15) 15
survival (15) 15
aged, 80 and over (14) 14
animals (14) 14
case-control studies (14) 14
stem-cell (14) 14
biomarkers, tumor - blood (13) 13
breast neoplasms - genetics (13) 13
cell proliferation (13) 13
research article (13) 13
analysis (12) 12
biomarkers, tumor - analysis (12) 12
breast neoplasms - mortality (12) 12
circulating tumor-cells (12) 12
neoplastic cells, circulating - drug effects (12) 12
treatment outcome (12) 12
biomarkers, tumor - metabolism (11) 11
breast neoplasms - therapy (11) 11
cells (11) 11
development and progression (11) 11
epithelial-mesenchymal transition (11) 11
genes (11) 11
immunohistochemistry (11) 11
keratin-19 - genetics (11) 11
medicine (11) 11
neoplastic cells, circulating (11) 11
polymerase chain reaction (11) 11
therapy (11) 11
young adult (11) 11
bone marrow - pathology (10) 10
bone marrow cells - metabolism (10) 10
diagnosis (10) 10
disease progression (10) 10
disease-free survival (10) 10
gene expression regulation, neoplastic (10) 10
health aspects (10) 10
her2 status (10) 10
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (10) 10
medicine & public health (10) 10
stage-i (10) 10
biochemistry & molecular biology (9) 9
biomarkers (9) 9
breast neoplasms - metabolism (9) 9
cancer cells (9) 9
cancer therapies (9) 9
chemotherapy, adjuvant (9) 9
dna methylation (9) 9
imatinib mesylate (9) 9
kaplan-meier estimate (9) 9
leukemia, myelogenous, chronic, bcr-abl positive - therapy (9) 9
molecular characterization (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0181211
Background To evaluate the phenotypic heterogeneity of circulating tumor cells (CTCs) based on the expression of proliferative, apoptotic and... 
ADJUVANT CHEMOTHERAPY | RNA-POSITIVE CELLS | MESENCHYMAL TRANSITION MARKERS | CISPLATIN | MULTIDISCIPLINARY SCIENCES | BONE-MARROW | PROGNOSTIC RELEVANCE | EARLY BREAST-CANCER | EXPRESSION | CARCINOMA | THORACIC RADIOTHERAPY | Leukocytes, Mononuclear - metabolism | Lung Neoplasms - drug therapy | Neoplastic Cells, Circulating - drug effects | Leukocytes, Mononuclear - drug effects | Neoplastic Cells, Circulating - pathology | Vimentin - metabolism | Humans | Lung Neoplasms - metabolism | Ki-67 Antigen - metabolism | Lung Neoplasms - pathology | Male | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - blood | Small Cell Lung Carcinoma - metabolism | Leukocytes, Mononuclear - pathology | Small Cell Lung Carcinoma - pathology | Aged, 80 and over | Cell Line, Tumor | Adult | Female | Aged | Lung Neoplasms - blood | Gene Expression Regulation, Neoplastic - drug effects | Care and treatment | Cancer cells | Physiological aspects | Lung cancer, Small cell | Research | Diagnosis | Risk factors | Vimentin | Mesenchyme | Laboratories | Lung cancer | Medical services | Antibodies | Staining | Oncology | Biology | Metastasis | Multivariate analysis | Medical schools | Incidence | Genotype & phenotype | Heterogeneity | Peripheral blood | Subpopulations | Small cell lung carcinoma | Tumor cells | Markers | Breast cancer | Radiation therapy | Patients | Chemotherapy | Blood circulation | Lungs | Immunofluorescence | Cancer | Apoptosis
Journal Article
Journal Article
Lung Cancer, ISSN 0169-5002, 2016, Volume 104, pp. 16 - 23
Highlights • Pazopanib is a small molecule with a tyrosine multikinase inhibitor activity. • CTCs detection could serve as a prognostic and predictive tool in... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | VEGFR2 | SCLC | TTF-1 | Immunofluorescence | CD56 | CellSearch | CTCs | Pazopanib | ADJUVANT CHEMOTHERAPY | BONE-MARROW | PERIPHERAL-BLOOD | TYROSINE KINASE INHIBITORS | RNA-POSITIVE CELLS | ONCOLOGY | RESPIRATORY SYSTEM | PROGNOSTIC-SIGNIFICANCE | OPERABLE BREAST-CANCER | TRANSCRIPTION FACTOR-I | THORACIC RADIOTHERAPY | CLINICAL-SIGNIFICANCE | Lung Neoplasms - drug therapy | Neoplastic Cells, Circulating - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Lung Neoplasms - pathology | Male | Vascular Endothelial Growth Factor Receptor-2 - immunology | Small Cell Lung Carcinoma - drug therapy | Leukocyte Common Antigens - immunology | Neoplasm Recurrence, Local - pathology | Small Cell Lung Carcinoma - metabolism | Angiogenesis Inhibitors - administration & dosage | Non-Randomized Controlled Trials as Topic | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | CD56 Antigen - immunology | Neoplastic Cells, Circulating - drug effects | DNA-Binding Proteins - immunology | Neoplasm Recurrence, Local - metabolism | Pyrimidines - administration & dosage | Angiogenesis Inhibitors - pharmacology | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Small Cell Lung Carcinoma - pathology | Aged | Transcription Factors | Sulfonamides - administration & dosage | Tyrosine | Medical colleges | Care and treatment | Relapse | Lung cancer | Metastasis | Angiogenesis inhibitors | Cells | Diseases | Analysis | Development and progression
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2010, Volume 21, Issue 7, pp. vii95 - vii100
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 05/2014, Volume 106, Issue 5
Journal Article
Scientific Reports, ISSN 2045-2322, 03/2017, Volume 7, Issue 1, p. 45351
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2012, Volume 18, Issue 20, pp. 5701 - 5710
Journal Article